The mGPS was significantly associated with age (p = 0.021), albumin (p < 0.001), CRP (p < 0.001), operative procedure (p = 0.021), tumor size (p < 0.001), tumor depth (p < 0.001), lymph node metastasis (p = 0.015), pTNM stage (p < 0.001), carcinoembryonic antigen (CEA) (p = 0.048), and postoperative complications (p < 0.001). The gene discussed is CRP; the disease is neoplasm.